newatlas.com / .newatlas-com-health-wellbeing / Page 2

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The Phase 1 trial will target senescent T cells, which accumulate as we age or fight chronic disease and become less good at ...

Scientists have not just uncovered a new way that aging cells drive inflammation, but they've also blocked this pathway with an existing Food and Drug Administration-approved medicine. This opens the door to an entirely new way to shield the body ...

David Michaels, George Washington University & Robert Harrison, University of California, San Francisco/The Conversation ...

We may be on the cusp of understanding whether we can turn back time for our cells to stave off age-related disease, with the first human receiving experimental gene therapy as part of a landmark trial.

We might be on the verge of a breakthrough treatment for pattern hair loss following clinical testing of a new oral medication called VDPHL01.

Susanne Durhuus-Andersen & Nuno Vibe Hermann, University of Copenhagen/ The Conversation ...

Anti-aging peptides have become one of the most talked-about experimental treatments in this emerging area of science - and one in particular, GHK-Cu, is now in the spotlight.

Grabbing that late-night kebab or pizza slice after a few drinks may not be a sign of poor willpower, but a biological drive that once would have seen us seek out protein but now leads us straight into the comforting arms of savory ultra-processed .. ...

The role of a traitorous antibody in triggering inflammatory bowel disease has been described in detail in a new study published this month in the New England Journal of Medicine.

The US has broken a two-decade drought with the Food and Drug Administration (FDA) adding bemotrizinol to the list of approved active ingredients that can be used in sunscreen, paving the way for more effective protection from ultraviolet (UV) light.